Basal Cell Carcinoma Surgery: Simple Undermining Approach in Two Patients with Different Tumour Locations

Authors

  • Georgi Tchernev Medical Institute of Ministry of Interior (MVR), Department of Dermatology and Dermatologic Surgery, General Skobelev 79, 1606 Sofia, Bulgaria; Onkoderma - Policlinic for Dermatology, Venereology and Dermatologic Surgery, 26 General Skobelev blvd., Sofia
  • Cristiana Voicu Dermatology Department, Polisano Clinic, 26Z Timisoara Blvd, Bucharest
  • Mara Mihai Oncologic Dermatology and Allergology Department, ”Carol Davila” University of Medicine and Pharmacy, 17 Marasti Blvd, Bucharest
  • Tiberiu Tebeica Dr Leventer Centre, 13-17 Sevastopol Street, Ste. 204, Bucharest 010991
  • Nely Koleva Medical Institute of Ministry of Interior (MVR), Department of Dermatology and Dermatologic Surgery, General Skobelev 79, 1606 Sofia
  • Uwe Wollina Department of Dermatology and Allergology, Academic Friedrichstrasse 41, 01067, Dresden
  • Torello Lotti Chair of Dermatology, University of Rome G. Marconi, Rome
  • Hristo Mangarov Medical Institute of Ministry of Interior (MVR), Department of Dermatology and Dermatologic Surgery, General Skobelev 79, 1606 Sofia
  • Ilko Bakardzhiev Medical College, Varna
  • Jacopo Lotti Department of Nuclear, Subnuclear and Radiation Physics, University of Rome "G. Marconi", Rome
  • Katlein França Institute for Bioethics & Health Policy; Department of Dermatology & Cutaneous Surgery; Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine - Miami, FL
  • Atanas Batashki Abdominal and Thoracic Surgery, Department of Special Surgery, Medical University of Plovdiv, bul. "Peshtersko shose" Nr 66, 4000 Plovdiv
  • James W. Patterson Department of Pathology, University of Virginia Health System, 1215 Lee Street, Box 800214, Charlottesville, VA 22908

DOI:

https://doi.org/10.3889/oamjms.2017.143

Keywords:

basal cell carcinoma, treatment, surgery, undermining, extendable plastic

Abstract

Basal cell carcinoma (BCC) is the most common human malignancy, accounting for the majority of all non-melanoma skin cancers (NMSC). In the past several decades the worldwide incidence of BCC has constantly been increasing. Even though it is a slow growing tumour that, left untreated, rarely metastasizes, it has a distinctive invasive growth pattern, posing a considerable risk for local invasion and destruction of underlying tissues, such as muscle, cartilage, bone or vital structures. Advanced BCCs include such locally invasive or metastatic tumours. Complete surgical excision is the standard therapy for most uncomplicated BCC cases with good prognosis and cure rates. Treatment of advanced forms of BCCs poses significant therapeutic challenges, most often requiring complicated surgery, radiotherapy, and/or targeted therapies directed towards the sonic hedgehog signalling pathway (SHH). We present two cases of large BCCs located on the scalp and posterior thorax, which underwent surgical excision with clear margins, followed by reconstruction of the defect after extensive undermining of the skin.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of the worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–1080. https://doi.org/10.1111/j.1365-2133.2012.10830.x PMid:22251204

Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. The increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA New Hampshire Skin Cancer Study Group. Int J Cancer. 1999;81:555–559. https://doi.org/10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R

McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. Eur J Cancer. 2014;50:774–783. https://doi.org/10.1016/j.ejca.2013.12.013 PMid:24412051

Chung S. Basal Cell Carcinoma. Arch Plast Surg. 2012; 39(2): 166–170. https://doi.org/10.5999/aps.2012.39.2.166 PMid:22783519 PMCid:PMC3385325

Dourmishev LA, Rusinova D, and Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013; 4(1): 12–17. https://doi.org/10.4103/2229-5178.105456 PMid:23439912 PMCid:PMC3573444

Cabrera HN, Gómez ML. Skin cancer induced by arsenic in the water. J Cutan Med Surg. 2003;7:106–11. https://doi.org/10.1177/120347540300700202 PMid:12447618

Chan PC, Haseman JK, Boorman GA, Huff J, Manus AG, Cardy RH. Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two years. Cancer Res. 1986;46:6349–52. PMid:3779651

Kubasiewicz M, Starzy-ski Z. Case-referent study on skin cancer and its relation to occupational exposure to polycyclic aromatic hydrocarbons. I. Study design. Pol J Occup Med. 1989;2:221–8. PMid:2489425

Emmert S, Schön MP, Haenssle HA. Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol. 2014;810:234-52. https://doi.org/10.1007/978-1-4939-0437-2_13

de Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol. 2010;51:81–92. https://doi.org/10.1111/j.1440-0960.2009.00579.x PMid:20546211

Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361:1164–1172. https://doi.org/10.1056/NEJMoa0905360 PMid:19726763

Berking C, Hauschild A, Oliver Kölbl O, Mast G, Gutzmer R. Basal Cell Carcinoma—Treatments for the Commonest Skin Cancer. Dtsch Arztebl Int. 2014 May; 111(22): 389–395. PMid:24980564 PMCid:PMC4078227

Mohan S. V., Chang A.L.S. Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations. Curr Dermatol Rep. 2014; 3(1): 40–45. https://doi.org/10.1007/s13671-014-0069-y PMid:24587976 PMCid:PMC3931971

Tchernev G, Pidakev I, Lozev I, Lotti T, Cardoso JC, Patterson JW. Undermining plastic surgery as a possible option for treating basal cell carcinoma of the forehead. Wien Med Wochenschr. 2017 Feb 13. https://doi.org/10.1007/s10354-017-0542-x

Archontaki M, Stavrianos SD, Korkolis DP, Arnogiannaki N, Vassiliadis V, Liapakis IE, Christ H, Rapidis AD, Kokkalis G. Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 2009; 29(7):2655-63. PMid:19596942

Doan H Q, Silapunt S, Migden M R. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. Onco Targets Ther. 2016; 9: 5671–5678. https://doi.org/10.2147/OTT.S108171 PMid:27695345 PMCid:PMC5028081

Wollina U, Tchernev G. Advanced basal cell carcinoma. Wien Med Wochenschr 2013; 163(15-16):347-53. https://doi.org/10.1007/s10354-013-0193-5 PMid:23589318

Bogdanić B, Smud S, Bagatin D, Nola M, Mijatović D, Majerović M. Giant basal cell carcinoma of the back: a case report and review of the literature. Coll Antropol. 2009;33(1):315-8. PMid:19408644

Cho M, Lee J, James CL, Marshman G, Huilgol SC. Scalp Basal Cell Carcinoma: Review of 2,202 Cases. Dermatol Surg. 2016;42(7):834-41. https://doi.org/10.1097/DSS.0000000000000783 PMid:27243131

Ching JA, Curtis HL, Braue JA, Kudchadkar RR, Mendoza TI et all. The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma. Ann Plast Surg. 2015;74 Suppl 4:S193-7. https://doi.org/10.1097/SAP.0000000000000452 PMid:25695449

Raposio E, Nordström RE, Santi PL. Undermining of the scalp: quantitative effects. Plast Reconstr Surg. 1998 Apr;101(5):1218-22. https://doi.org/10.1097/00006534-199804010-00007

Published

2017-07-24

How to Cite

1.
Tchernev G, Voicu C, Mihai M, Tebeica T, Koleva N, Wollina U, Lotti T, Mangarov H, Bakardzhiev I, Lotti J, França K, Batashki A, Patterson JW. Basal Cell Carcinoma Surgery: Simple Undermining Approach in Two Patients with Different Tumour Locations. Open Access Maced J Med Sci [Internet]. 2017 Jul. 24 [cited 2022 Dec. 6];5(4):506-10. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2017.143

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>